80 likes | 97 Views
The Defibrillator market is projected to reach US$ 14,876.95 million by 2028 from US$ 10,478.31 million in 2021. It is estimated to grow at a CAGR of 5.1% % from 2021 to 2028. Several factors, such as the increasing prevalence of cardiovascular disorders along with surge in training and awareness programs on cardiopulmonary resuscitation and automated external defibrillators. However, cost and performance issues related to implantable and automated external defibrillators is expected to hamper market growth.<br>Defibrillators are devices that give a high energy shock to the heart of a patient who
E N D
Defibrillator Market Global Analysis and Forecast to 2028 Email: sales@theinsightpartners.com
Email: sales@theinsightpartners.com Report Studies Defibrillator Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Implantable Cardioverter Defibrillator (Transvenous ICD and Subcutaneous ICD) and External (Manual, Fully Automated External Defibrillators, and Wearable), End User (Hospitals and Clinics, Prehospital Care, Public Access, Alternate Care Facilities, and Home Care Settings), and Geography 2
Email: sales@theinsightpartners.com Defibrillator Market Overview The defibrillator market is projected to reach US$ 14,876.95 million by 2028 from US$ 10,478.31 million in 2021; it is expected to grow at a CAGR of 5.1% from 2021 to 2028. Defibrillators are devices that give a high energy shock to the heart of a patient who is in cardiac arrest. The increasing prevalence and incidence of cardiovascular diseases (CVDs) has led to the risk of cardiac dysrhythmias, specifically ventricular fibrillation (VF) and non- perfusing ventricular tachycardia (VT) among patients which can be treated through the use of defibrillators. A defibrillator can be external or implantable. An external defibrillator comes in various types, including manual, automated, and wearable. Whereas, an implantable defibrillator is usually implanted on or inside a patient and can be transvenous implantable cardioverter defibrillator (ICD) or subcutaneous ICD. 3
Email: sales@theinsightpartners.com Key Segment Market Segment :- By Product Type (Implantable Cardioverter Defibrillator (Transvenous ICD and Subcutaneous ICD) External (Manual, Fully Automated External Defibrillators, and Wearable) End User (Hospitals and Clinics, Prehospital Care, Public Access, Alternate Care Facilities, and Home Care Settings) Geography 4
Email: sales@theinsightpartners.com $50,000 Defibrillator Market Value $40,000 $30,000 CAGR of 5.1% $20,000 (2022-2028) $10,000 $0 20XX 20XX 20XX 20XX 20XX Download Sample 5
Email: sales@theinsightpartners.com Company Profiles Medtronic plc Abbott Laboratories Boston Scientific Corp. Koninklijke Philips NV Biotronik, Inc. Zoll Medical Corp. Nihon Kohden Corp. Progetti srl CU Medical Systems, Inc. Shenzhen Mindray Biomedical Electronics Co., Ltd. 6 Download Sample Here
Email: sales@theinsightpartners.com By Geography North America (the US, Canada, and Mexico) Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe) Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific) Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa) South & Central America (Brazil, Argentina, and the Rest of South & Central America). 7
THANK YOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com